{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Gonzalez KA"],"funding":["National Institute of Aging","NIA NIH HHS","National Institutes of Health","National Science Foundation"],"pagination":["e0270289"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9467319"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["17(9)"],"pubmed_abstract":["<h4>Objective</h4>Type 2 Diabetes Mellitus (henceforth diabetes) affects roughly 35 million individuals in the US and is a major risk factor for cardiovascular and kidney disease. Serum Cystatin-C is used to monitor renal function and detect kidney damage. Recent research has focused on linking Cystatin-C to cardiovascular risk and disease, but most findings focus on small sample sizes and generalize poorly to diverse populations, thus limiting epidemiological inferences. The aim of this manuscript is to study the association between Cystatin-C, diabetes, and mortality and test for possible sex or racial/ethnic background modifications in these relationships.<h4>Methods</h4>We analyzed 8-years of biennial panel data from Health and Retirement Study participants 50-years and older who self-"],"journal":["PloS one"],"pubmed_title":["Serum Cystatin-C is linked to increased prevalence of diabetes and higher risk of mortality in diverse middle-aged and older adults."],"pmcid":["PMC9467319"],"funding_grant_id":["P30AG059299","2021292286","RF1 AG061022","R01-AG048642","R01 AG048642","P30AG062429","RF1 AG054548","P30 AG059299","P30 AG062429"],"pubmed_authors":["Ramos AR","Tarraf W","Kaur SS","Stickel AM","Gonzalez KA","Gonzalez HM"],"additional_accession":[]},"is_claimable":false,"name":"Serum Cystatin-C is linked to increased prevalence of diabetes and higher risk of mortality in diverse middle-aged and older adults.","description":"<h4>Objective</h4>Type 2 Diabetes Mellitus (henceforth diabetes) affects roughly 35 million individuals in the US and is a major risk factor for cardiovascular and kidney disease. Serum Cystatin-C is used to monitor renal function and detect kidney damage. Recent research has focused on linking Cystatin-C to cardiovascular risk and disease, but most findings focus on small sample sizes and generalize poorly to diverse populations, thus limiting epidemiological inferences. The aim of this manuscript is to study the association between Cystatin-C, diabetes, and mortality and test for possible sex or racial/ethnic background modifications in these relationships.<h4>Methods</h4>We analyzed 8-years of biennial panel data from Health and Retirement Study participants 50-years and older who self-","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-19T07:08:12.157Z","creation":"2025-04-19T07:08:12.157Z"},"accession":"S-EPMC9467319","cross_references":{"pubmed":["36094936"],"doi":["10.1371/journal.pone.0270289"]}}